James R. Kasinger, General Counsel and Secretary at CRISPR Therapeutics AG (CRSP), sold 2,178 shares at $46.28 ($101K) on 2024-10-14, disclosed to the SEC on 2024-10-15.
Open-market sale of $101k CRSP by General Counsel and Secretary. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $46.28 | 1,089 | $50K | 50.0% |
| 2 | $46.28 | 1,089 | $50K | 50.0% |
| Total | $46.28 avg | 2,178 | $101K | 100% |
| Filing → |
| CRSP | SELL | 2026-03-17 | $166K | — | Filing → |
| CRSP | SELL | 2026-03-12 | $148K | — | Filing → |
| CRSP | SELL | 2026-02-20 | $111K | — | Filing → |